Table 1 Baseline characteristics and preoperative echocardiographic data
Variables | Surgical group (%) | Ablation group (%) | P value |
|---|---|---|---|
Baseline characteristics | |||
Age(years) | 63 ± 5.7 | 65 ± 5.9 | 0.3697 |
Male | 38 (63.3) | 40 (60.6) | 0.3235 |
BSA(m2) | 1.68 ± 0.16 | 1.66 ± 0.12 | 0.5247 |
Hypertension | 16 (26.7) | 18 (27.3) | 0.9390 |
Diabetes | 10 (16.7) | 13 (19.7) | 0.6601 |
COPD | 4 (6.7) | 5 (7.6) | 1.0000 |
Coronary disease | 9 (15.0) | 10 (15.1) | 0.9811 |
Previous MI | 2 (3.3) | 4 (6.1) | 0.7648 |
Previous stroke/TIA | 7 (11.7) | 10 (15.1) | 0.5674 |
Renal failure | 1 (1.7) | 1 (1.5) | 1.0000 |
NYHA classifications | |||
I ~ II | 21 (35.0) | 25 (37.9) | 0.7375 |
III | 39 (65.0) | 41 (62.1) | 0.7375 |
IV | 0 | 0 | – |
Duration of AF (months) | 19 ± 9.6 | 20 ± 7.6 | 0.4124 |
Previous AF ablations | 0 | 0 | – |
EuroSCORE II, % | 2.5 (1.6–4.1) | 2.4 (1.2–4.0) | 0.5128 |
STS PROM score, % | 3.7 (2.2–5.8) | 3.5 (2.0–5.7) | 0.4682 |
Echocardiographic characteristics | |||
LA volume (ml) | 119 ± 49 | 116 ± 45 | 0.2927 |
LVEDD (mm) | 49 ± 6.0 | 48 ± 6.8 | 0.3061 |
LVESD (mm) | 37 ± 6.1 | 38 ± 6.4 | 0.2167 |
IVS (mm) | 10 ± 1.0 | 10 ± 0.8 | 0.5871 |
LVEF (%) | 56 ± 8.2 | 58 ± 8.5 | 0.3150 |
Moderate-severe MR | 60 (100) | 66 (100) | 0.1994 |
Moderate-severe TR | 46 (76.7) | 50 (75.8) | 0.9048 |